HUP0303431A2 - PRRS vírus élő legyengített törzsei - Google Patents

PRRS vírus élő legyengített törzsei

Info

Publication number
HUP0303431A2
HUP0303431A2 HU0303431A HUP0303431A HUP0303431A2 HU P0303431 A2 HUP0303431 A2 HU P0303431A2 HU 0303431 A HU0303431 A HU 0303431A HU P0303431 A HUP0303431 A HU P0303431A HU P0303431 A2 HUP0303431 A2 HU P0303431A2
Authority
HU
Hungary
Prior art keywords
viruses
prrs
live attenuated
prrs virus
attenuated strains
Prior art date
Application number
HU0303431A
Other languages
English (en)
Hungarian (hu)
Inventor
Knut Elbers
Stefan Peschke
Bettina Schuetz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of HUP0303431A2 publication Critical patent/HUP0303431A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10061Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10061Methods of inactivation or attenuation
    • C12N2770/10062Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HU0303431A 2001-03-09 2002-03-07 PRRS vírus élő legyengített törzsei HUP0303431A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27460301P 2001-03-09 2001-03-09
PCT/EP2002/002486 WO2002072802A2 (fr) 2001-03-09 2002-03-07 Souches vivantes attenuees de virus sdrp

Publications (1)

Publication Number Publication Date
HUP0303431A2 true HUP0303431A2 (hu) 2004-01-28

Family

ID=23048885

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303431A HUP0303431A2 (hu) 2001-03-09 2002-03-07 PRRS vírus élő legyengített törzsei

Country Status (12)

Country Link
EP (1) EP1421184A2 (fr)
JP (1) JP2004534522A (fr)
KR (1) KR20030082960A (fr)
BR (1) BR0207988A (fr)
CA (1) CA2439254A1 (fr)
CZ (1) CZ20032743A3 (fr)
HU (1) HUP0303431A2 (fr)
MX (1) MXPA03007751A (fr)
PL (1) PL370541A1 (fr)
RU (1) RU2003129068A (fr)
SK (1) SK11282003A3 (fr)
WO (1) WO2002072802A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438969A1 (fr) * 2003-01-14 2004-07-21 Universiteit Utrecht Vaccin marqueur d'aterivirus
KR20050040172A (ko) * 2003-10-27 2005-05-03 주식회사 중앙백신연구소 돼지 생식기호흡기 증후군 바이러스 불활화 백신의 제조방법
ATE479440T1 (de) * 2004-11-19 2010-09-15 Intervet Int Bv Virusstämme und zusammensetzungen des prrs- syndroms (porcine reproductive und respiratory syndrome) von schweinen
RU2381035C2 (ru) * 2005-02-25 2010-02-10 Пфайзер Продактс Инк. Композиция для защиты свиней от инфекции ррсс-вируса (варианты) и вакцина, содержащая указанную композицию (варианты)
WO2009008924A2 (fr) 2007-04-05 2009-01-15 Mount Sinai School Of Medicine Of New York University Procédés permettant de prévenir et de traiter les infections virales en inhibant l'activité de suppression de l'isg des protéines virales contenant le domaine otu
CN101454442A (zh) * 2007-06-15 2009-06-10 普泰克国际有限公司 嵌合体prrsv的构建,组合物及疫苗的制备
US7666585B2 (en) 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
ES2550258T3 (es) * 2011-02-17 2015-11-05 Boehringer Ingelheim Vetmedica Gmbh Nueva cepa del PRRSV europea
KR101420850B1 (ko) * 2011-05-30 2014-08-13 건국대학교 산학협력단 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신
KR101281361B1 (ko) * 2011-07-18 2013-07-02 서울대학교산학협력단 북미형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물 및 이를 포함하는 혼합백신 조성물
KR101245029B1 (ko) * 2012-01-18 2013-03-18 서울대학교산학협력단 한국형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물
CA2872789C (fr) * 2012-05-17 2019-09-03 Zoetis Llc Vaccination efficace contre le virus du syndrome reproducteur et respiratoire porcin (srrp) avant le sevrage
CN103290142B (zh) * 2013-03-29 2015-03-11 云南农业大学 荧光定量rt-pcr检测猪蓝耳病弱毒疫苗病毒含量的方法
KR101624485B1 (ko) 2014-08-13 2016-05-26 전북대학교산학협력단 돼지생식기호흡기증후군 바이러스(prrsv) 변이주 및 이를 포함하는 돼지 생식기 호흡기 증후군 예방 또는 치료용 백신 조성물
CN104694561B (zh) * 2015-02-10 2018-02-23 中国农业科学院上海兽医研究所 表达海肾或萤火虫荧光素酶基因的prrsv重组质粒的构建方法以及应用
CN119876049A (zh) * 2019-08-29 2025-04-25 礼蓝美国公司 猪繁殖与呼吸综合征疫苗病毒
KR102276341B1 (ko) * 2020-01-29 2021-07-12 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 제조 방법 및 이의 용도
EP4098741A4 (fr) * 2020-01-29 2024-04-03 Biopoa, Inc. Souche mutante du virus du syndrome reproducteur et respiratoire porcin européen, et vaccin l'utilisant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69201441T3 (de) * 1991-06-06 2008-12-04 Boehringer Ingelheim Vetmedica Gmbh Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
EP1882696A3 (fr) * 1997-05-06 2008-03-05 Boehringer Ingelheim Vetmedica Gmbh Sites antigéniques du PRRSV identifiant des séquences peptidiques du virus PRRSV à utiliser dans des vaccins ou des analyseurs de diagnostic
AU7960598A (en) * 1997-06-05 1998-12-21 Origen, Inc. Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
CA2366072C (fr) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Vaccins contre le virus du syndrome dysgenesique respiratoire porcin (srdp)
EP1254213A2 (fr) * 2000-01-26 2002-11-06 Boehringer Ingelheim Vetmedica Gmbh Attenuation recombinante de virus sdrp
EP1156111A1 (fr) * 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Particules chimériques de type arterivirus
WO2001089559A2 (fr) * 2000-05-24 2001-11-29 Merial Vaccin a poxvirus recombinant contre le virus du syndrome disgenesique respiratoire porcin (vsdrp)
EP1397498A1 (fr) * 2001-05-21 2004-03-17 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Deletions des replicons de l'arterivirus

Also Published As

Publication number Publication date
WO2002072802A2 (fr) 2002-09-19
KR20030082960A (ko) 2003-10-23
WO2002072802A3 (fr) 2004-03-11
CZ20032743A3 (cs) 2004-02-18
JP2004534522A (ja) 2004-11-18
PL370541A1 (en) 2005-05-30
RU2003129068A (ru) 2005-04-10
SK11282003A3 (sk) 2004-02-03
MXPA03007751A (es) 2004-11-12
EP1421184A2 (fr) 2004-05-26
BR0207988A (pt) 2004-10-26
CA2439254A1 (fr) 2002-09-19

Similar Documents

Publication Publication Date Title
HUP0303431A2 (hu) PRRS vírus élő legyengített törzsei
HUP0203056A1 (hu) Vakcinakészítmény
HUP0301180A2 (hu) Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban
CY1106334T1 (el) Βελτιστοποιημενου κωδικονιου αλληλουχιες ιου θηλωματος
EA200501890A1 (ru) Вирусы гриппа высокого титра для приготовления вакцин и генной терапии
CY1109463T1 (el) Πεπτιδια kdr και εμβολια που τα περιλαμβανουν
HUP0102304A1 (hu) B Csoportba tartozó Streptococcus antigének
RU2007139915A (ru) Haemophilus influenzae типа в
MXPA01011047A (es) Secuencias genomicas de neisseria y metodos para su uso.
EE05633B1 (et) Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine
NZ543467A (en) The severe acute respiratory syndrome coronavirus
MXPA05011110A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
AU2002248384A1 (en) Serpin drugs for treatment of hiv infection and method of use thereof
HUP0402259A2 (hu) Vakcinák
DK0495896T3 (da) Vaccine til beskyttelse mod HIV-virusinfektioner, fremgangsmåde til fremstilling heraf og anvendelse heraf som diagnostisk middel og immunterapeutisk middel
TW200502246A (en) Vaccine
HUP0203335A1 (hu) Vakcina
HUP0302612A2 (hu) Salmonella vakcina
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
IS8254A (is) örugg stökkbreytt veirubóluefni
JP2006512078A5 (fr)
WO2003080112A3 (fr) Adjuvant
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
AR027291A1 (es) Atenuacion recombinante de prrsv
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden